Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-03-06 @ 2:56 PM
Study NCT ID:
NCT03123393
Status:
TERMINATED
Last Update Posted:
2023-02-08
First Post:
2017-04-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Sponsor:
Calithera Biosciences, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C34004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None